Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTP) Equity Ratio (2022 - 2025)

Historic Equity Ratio for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to 0.66.

  • 60 Degrees Pharmaceuticals' Equity Ratio fell 1757.78% to 0.66 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66, marking a year-over-year decrease of 1757.78%. This contributed to the annual value of 0.7 for FY2024, which is 1367.27% up from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Equity Ratio stood at 0.66 for Q3 2025, which was down 1757.78% from 0.56 recorded in Q2 2025.
  • Over the past 5 years, 60 Degrees Pharmaceuticals' Equity Ratio peaked at 0.85 during Q1 2024, and registered a low of 18.62 during Q4 2022.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Equity Ratio averaged around 1.43, with its median value being 0.67 (2025).
  • In the last 5 years, 60 Degrees Pharmaceuticals' Equity Ratio soared by 12036.42% in 2024 and then plummeted by 2074.57% in 2025.
  • 60 Degrees Pharmaceuticals' Equity Ratio (Quarter) stood at 18.62 in 2022, then surged by 103.31% to 0.62 in 2023, then grew by 13.67% to 0.7 in 2024, then decreased by 5.48% to 0.66 in 2025.
  • Its last three reported values are 0.66 in Q3 2025, 0.56 for Q2 2025, and 0.67 during Q1 2025.